Cancer drug company wins key nod from regulators

  • By Business Observer Staff
  • | 2:51 a.m. November 28, 2016
  • Tampa Bay-Lakeland
  • Share

TAMPA — Federal regulators granted a Fast Track designation to a product developed to treat oral mucositis, a painful adverse effect from chemotherapy and radiotherapy that can lead to inflammation of the digestive tract.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 3, 2026
Net-zero Cortez community selects company to handle rentals
  • April 2, 2026
Sarasota Doctors Hospital names new COO
  • April 2, 2026
Babcock Ranch shopping center gets refinance
  • April 2, 2026
Report: Childhood poverty pockets remain in region amid Florida decline

Sponsored Content